Covered recipient · General Payments record
LANCE A HANSEN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,616.80
- Reported across 100 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $262.61 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $149.58 | 8 |
| Novo Nordisk AS | $28.34 | 2 |
| Phathom Pharmaceuticals, Inc. | $27.49 | 2 |
| Xeris Pharmaceuticals, Inc. | $23.87 | 1 |
| Tris Pharma Inc | $20.17 | 1 |
| Regeneron Healthcare Solutions, Inc. | $13.16 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.29 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103876206 | CMS |
| ABBVIE INC. | $2.82 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103876208 | CMS |
| ABBVIE INC. | $34.93 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103876210 | CMS |
| ABBVIE INC. | $19.75 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103876212 | CMS |
| ABBVIE INC. | $25.42 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103876214 | CMS |
| ABBVIE INC. | $14.60 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103876216 | CMS |
| ABBVIE INC. | $11.85 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103876218 | CMS |
| ABBVIE INC. | $17.92 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103876220 | CMS |
| Novo Nordisk Inc | $13.62 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096872691 | CMS |
| Novo Nordisk Inc | $14.72 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096780101 | CMS |
| Phathom Pharmaceuticals, Inc. | $13.76 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151069875 | CMS |
| Phathom Pharmaceuticals, Inc. | $13.73 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151069877 | CMS |
| Regeneron Healthcare Solutions, Inc. | $13.16 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114064698 | CMS |
| Tris Pharma Inc | $20.17 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147213341 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.87 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144602157 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.